Monday, May 21 - Wednesday, May 23 Howard University // Washington, D.C.

Event Underwriter Presenting Sponsor Recovery Advocacy Sponsor

Monday, May 21National Leadership Conference Day 1

3:00pm: Check in at Howard UniversityDrew Hall520 Harvard St., NWWashington, DC 20001

5:00-6:00pm: Dinner The Café at Armour J. Blackburn University Center2397 6th St., NW Washington, DC 20059

8:00-9:00pm: All-Recovery Meeting Drew Hall Common Room

Tuesday, May 22National Leadership Conference Day 2

7:00-8:30am: Breakfast The Café at Armour J. Blackburn University Center

9:00-10:00am: SBIRT 101 Drew Hall Common Room

10:10-11:00am: Chapter Presentation #1Drew Hall Common Room

11:10-12:00pm: Chapter Presentation #2Drew Hall Common Room

12:00-1:00pm: Lunch The Café at Armour J. Blackburn University Center

AGENDA

1:30-2:15pm: Chapter Presentation #3Drew Hall Common Room

2:30-4:30pm: Advocacy TrainingCapitol Decisions, Inc.Drew Hall Common Room

4:30-5:00pm: Break

5:00-6:00pm: DinnerThe Café at Armour J. Blackburn University Center

6:00-8:00pm: Free Time

8:15-9:30pm: Awards Presentation and Data OverviewDrew Hall Common Room

Wednesday, May 23Hill Day Advocacy & Education Event

7:00-7:45am: BreakfastThe Café at Armour J. Blackburn University Center

7:45-8:00am: Dorm checkout/Key drop-off

8:15am: Bus to Capitol

9:00-12:50pm: Hill Day Visits (Round 1)

1:00pm: Bus to Airport (Round 1)

1:00-3:50pm: Hill Day Visits (Round 2)

4:00pm: Bus to Airport (Round 2)

Young People in Recovery Staff: Justin Luke Riley, President & CEO Ann Herbst, VP, Institutional Advancement Hugh Guill, VP, Programs Franklin Erickson, Program CoordinatorTara Moseley, Program ManagerMolly Smith, Program ManagerMichael Miller, Communications & Chapter Director Jenna Lee Gastineau, Business Operations CoordinatorAaron Young, Creative Design Consultant

Regional Chapter Coordinators:

Justin HughesAndrew KiezulasMolly SmithLaurie Sweeney

Participating YPR Chapter Leads:CALIFORNIATed Collins, YPR-Los Angeles (YPR Board Secretary)

COLORADOKaren Walker, YPR-Adams CountyGabrielle Rodriguez, YPR-Aurora Joe Martinez, YPR-DenverCandice Rose Seay, YPR-DurangoLexi Roselle, YPR-Pueblo

CONNECTICUTKenyetta Banks, YPR-New Haven

GEORGIAChristian Frazier, YPR-Augusta

INDIANAKedric Martin, YPR-Lafayette

KENTUCKYMolly Boone, YPR-BardstownTiffany Dick, YPR Bowling GreenJenni Meredith, YPR-Louisville

LOUISIANALindsay Guillory, YPR-Lafayette

MAINECourtney Allen, YPR-AugustaMatthew Braun, YPR-BiddefordKayla Kalel, YPR-BrewerJeremy Hiltz, YPR-LewistonJesse Harvey, YPR-PortlandJasmin Pike, YPR-RocklandAshley Homestead, YPR-Westbrook

MONTANATaylre Sweeney, YPR-Lewiston

NEW HAMPSHIRECharlie MacLennan, YPR-Manchester

NEW JERSEYErik Beresnoy, YPR-Ocean County

OHIOToni Jackson, YPR-ClevelandMichael Plas, YPR-Lorain County

PENNSYLVANIAEdward Cortazar, YPR-Northeast PA (regional chapter)John Fabiseski, YPR-Northeast PA (regional chapter)Joanne Perri, YPR-Northeast PA (regional chapter)Becci Warren, YPR-Northeast PA (regional chapter)Sean Rodgers, YPR-PhiladelphiaMegan Overby, YPR-State College

TEXASFeldon Bonner, YPR-Houston

UTAHChris Rufflan, YPR-Salt Lake CityAdam Baxter, YPR-Tooele CountyRaschelle Hoffman, YPR-West Salt Lake City

Guest Speakers:SBIRT 101 Trainer: James PeckPsychologist III/Sr. Clinical Trainer at UCLA Integrated Substance Abuse Programs

James Peck, Psy.D. is a licensed clinical psychologist and senior clinical trainer at the UCLA Integrated Substance Abuse Programs (ISAP). For nearly a decade, Dr. Peck conducted Phase II clinical trials of behavioral and pharmacological interventions for stimulant dependence. Dr. Peck has extensive experience conducting curriculum development, clinical trainings, and clinical supervision on the etiology, assessment, and treatment of substance-related disorders, and on the treatment of individuals with co-occurring substance-related and psychiatric disorders. He currently works at UCLA in a primarily clinical training role, and maintains a busy practice

treating individuals with co-occurring disorders including HIV and HCV.

Hill Day Advocacy Trainer: Carol McDaidPrincipal, Capitol Decisions, Inc. YPR Board Chair

For over two decades, Carol McDaid has worked with leading drug and alcohol treatment centers, addiction physicians, prevention and consumer organizations and mental health consumer and provider organizations to refine public policy addressing addiction and mental health. With over 25 years of Federal legislative experience in Washington, Ms. McDaid provides clients with public affairs consulting on issues that span the breadth of health care, including behavioral health, Medicare, Medicaid, and private sector reimbursement issues. Capitol Decisions also served as consultants to the Coalition to Stop Opioid Overdose (CSOO) who were

part of the successful effort to pass the bi-partisan Comprehensive Addiction and Recovery Act in 2016. Because Ms. McDaid personally struggled with addiction, she understands the challenges, political and personal, of dealing with alcohol and drug issues. In 2004, Ms. McDaid co-founded the McShin Foundation in Richmond, Virginia with her husband, John Shinholser. In 2007, she received the Johnson Institute’s America Honors Recovery Award.

Kaléo is a pharmaceutical company dedicated to building innovative solutions for serious and life-threatening medical conditions. Our overall vision is to empower patients to gain freedom from their medical conditions. Kaléo’s guiding philosophy is that together, we build solutions for life.

APPROACHKaléo is a pharmaceutical company dedicated to building innovative solutions for serious and life-threatening medical conditions. Kaléo believes you are the expert on how your medical condition impacts your life, so we bring you into the product development process. Each kaléo product combines an established drug with an innovative delivery platform with the goal of achieving superiority over the current standard of care and cost effectiveness. Ultimately, the goal is to provide peace of mind.

In every therapeutic area, the kaléo goal is the same: to work together with patients and other users in order to develop better alternatives to the currently available standard of care. Kaléo’s management team has deep experience and knowledge of diverse aspects of pharmaceutical development and commercialization.

But kaléo also shares a common passion – you remain our central focus in every aspect of what we do. It is only with your insights that we may better understand your personal medical conditions, so we may continue to innovate and produce superior healthcare solutions.

HISTORYWhen kaléo’s founders, twin brothers Eric and Evan Edwards, were young children, they were diagnosed with life-threatening allergies to a wide range of items, including peanuts, tree nuts, seafood and eggs, they were taught to carry a dose of epinephrine with them at all times. Over time, however, they became increasingly frustrated that their potentially life-saving epinephrine delivery systems were awkward to carry and difficult to use. Eric and Evan decided to develop another option for patients like themselves and, in their late teens, conceived a new epinephrine delivery system. This led to the formation of Intelliject, later renamed kaléo.

111 Virginia Street, Ste 300, Richmond, VA 23219 Phone (804) 545-6360 Fax (804) 545-6219 www.kaleopharma.com

Alkermes plc is a fully integrated global biopharmaceutical

company that applies its scientific expertise and technological

know-how to develop innovative medicines for the treatment

of central nervous system (CNS) diseases, including

schizophrenia, depression, addiction and multiple sclerosis.

For more information about Alkermes, please visit:

www.alkermes.com